CIK 0001528115 · Non-accelerated filer<br>Smaller reporting company
Annexon, Inc.
Sign in to watch- Ticker
- ANNX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 275414423
- Phone
- (650) 822-5500
- Business address
- 1400 SIERRA POINT PARKWAY, BLDG C, SUITE 200, BRISBANE, CA, 94005
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change · Regulation FD disclosure
- 4 Open-market sale President & CEO sold 7,500 shares at $22.05 ($165,341)
- 4 Open-market sale EVP & Chief Scientific Officer sold 16,190 shares at $20.00 ($323,860)
- 4 Open-market sale EVP & Chief Financial Officer sold 3,500 shares at $20.01 ($70,034)
- SC 13D/A Stake Beneficial Ownership Report
- S-3ASR Offering Registration Statement
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 8-K Event Results of operations · Executive or director change
- 10-Q Report Quarterly Report
- 8-K Event Regulation FD disclosure
- 4 Open-market sale President & CEO sold 7,500 shares at an average $22.43 ($168,230)
- 8-K Event Shareholder vote results
- 4 Open-market sale EVP & Chief Scientific Officer sold 15,000 shares at an average $21.49 ($322,325)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 21 of 27 · 524 filings